propiolactone has been researched along with Pneumococcal Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alderson, M; Anderson, P; Campos, IB; Cardoso, CP; Dias, WO; Fratelli, F; Gonçalves, VM; Leite, LC; Liberman, C; Maisonneuve, JF; Malley, R; Robertson, G; Sbrogio-Almeida, ME; Silva, EP; Tate, A | 1 |
Alderson, M; Anderson, P; Dias, Wde O; Fratelli, F; Gonçalves, VM; Graca, R; Leite, L; Liberman, C; Lu, YJ; Maisonneuve, JF; Malley, R; Robertson, G; Sayeed, S; Tate, A; Thompson, CM | 1 |
2 other study(ies) available for propiolactone and Pneumococcal Infections
Article | Year |
---|---|
Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability.
Topics: Animals; Antibodies, Bacterial; Bioreactors; Female; Fermentation; Immunoglobulin G; Mice; Mice, Inbred BALB C; Microbial Viability; Pneumococcal Infections; Pneumococcal Vaccines; Propiolactone; Quality Control | 2014 |
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; CD4-Positive T-Lymphocytes; Female; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Propiolactone; Rabbits; Sepsis | 2010 |